OCTREOTIDE ACETATE

Generic: OCTREOTIDE ACETATE

Teva PharmaceuticalsManufacturer
INTRAMUSCULARRoute
2023-12-05Original Approval

OCTREOTIDE ACETATE is FDA application ANDA210317, sponsored by TEVA PHARMS USA INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DIARRHOEA
252 reports
2
NAUSEA
196 reports
3
FATIGUE
189 reports
4
OFF LABEL USE
171 reports
5
ABDOMINAL PAIN
161 reports
6
DEATH
144 reports
7
PRODUCT USE IN UNAPPROVED INDICATION
140 reports
8
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
123 reports
9
DRUG INEFFECTIVE
120 reports
10
MALIGNANT NEOPLASM PROGRESSION
120 reports